Storage of Sputum in Cetylpyridinium Chloride, OMNIgene.SPUTUM, and Ethanol Is Compatible with Molecular Tuberculosis Diagnostic Testing

C N'Dira Sanoussi, Bouke C de Jong, Dissou Affolabi, Conor J Meehan, Mathieu Odoun, Leen Rigouts, C N'Dira Sanoussi, Bouke C de Jong, Dissou Affolabi, Conor J Meehan, Mathieu Odoun, Leen Rigouts

Abstract

We compared cetylpyridinium chloride (CPC), ethanol (ETOH), and OMNIgene.SPUTUM (OMNI) for 28-day storage of sputum at ambient temperature before molecular tuberculosis diagnostics. Three sputum samples were collected from each of 133 smear-positive tuberculosis (TB) patients (399 sputum samples). Each patient's sputum was stored with either CPC, ETOH, or OMNI for 28 days at ambient temperature, with subsequent rpoB amplification targeting a short fragment (81 bp, GeneXpert MTB/RIF [Xpert]) or a long fragment (1,764 bp, in-house nested PCR). For 36 patients, Xpert was also performed at baseline on all 108 fresh sputum samples. After the 28-day storage (D28), Xpert positivity did not significantly differ between storage methods. In contrast, higher positivity for rpoB nested PCR was obtained with OMNI (n = 125, 94%) than with ETOH (n = 114, 85.7%; P = 0.001). Smears with scanty acid-fast bacilli (AFB) had lower rpoB PCR positivity with ETOH storage (n = 10, 41.7%) than with CPC (n = 16, 66.7%; difference, 25%; 95% confidence interval [CI], 3.5 to 46.5; P = 0.031) or OMNI (n = 16, 69.6%; difference, 26.1%; 95% CI, 3.8 to 48.4; P = 0.031), with no difference between CPC and OMNI. Poststorage, the threshold cycle (CT ) values significantly decreased compared to those prestorage with ETOH (difference, -1.1; 95% CI, -1.6 to -0.6; P = 0.0001) but not with CPC (P = 0.915) or OMNI (P = 0.33). For one patient's ETOH- and CPC-stored specimens with a CT of <10, Xpert gave results of rifampin false resistant at D28, which was resolved by repeating Xpert on a 1/100 diluted specimen. In conclusion, 28-day storage of sputum in OMNI, CPC, or ETOH at ambient temperature does not impact short-fragment PCR (Xpert), including for low smear grades. However, for long-fragment PCR, ETOH yielded a lower PCR positivity for low smear grades, while the performance of OMNI and CPC was excellent for all smear grades. (The study has been registered at ClinicalTrials.gov under registration number NCT02744469.).

Keywords: AFB scanty; OMNIgene.SPUTUM; Xpert; cetylpyridinium chloride; ethanol; isolate; molecular tests; short/long-fragment PCR; sputum; storage.

Copyright © 2019 Sanoussi et al.

Figures

FIG 1
FIG 1
Flow diagram for specimens and methods.
FIG 2
FIG 2
Algorithm for the choice of the suitable reagent for the storage of sputum for TB diagnostics. 1, Molecular tests on the stored sputum (direct molecular tests); 2, from up to 28 days (present study) to 2 to 7 years (20); 3, previously showed by Affolabi et al. (21); 4, extra washing required before inoculation on culture medium (2, 21, 25); 5, reduced/delayed growth after OMNI storage (2, 22, 23); 6, CPC is not compatible with direct MGIT inoculation (24), with reduced/delayed positivity (25), but washing off the CPC prior to inoculation in MGITs (2, 21, 25) increases the culture positivity rate (25); 7, cost OMNI > CPC > ETOH, shipping restriction for specimens stored with CPC and OMNI (IATA category B); 8, when Xpert CT values are <10, a RIF-resistant result should be confirmed on a dilution (1/100) of the remaining sample or a new sample if no leftover remains; 9, not optimal with higher temperature (≥37°C tested in this study), ETOH has shipping restrictions: dangerous good if total volume is >100 ml; 10, short decontamination required before inoculation on culture medium (21); LJ, Löwenstein-Jensen medium; MGIT, mycobacterial growth indicator tube (manual or automated); LJ/MGIT, for LJ or MGIT; CPC/OMNI/ETOH, use either CPC, OMNI, or ETOH; CPC/OMNI, use either CPC or OMNI.

References

    1. Williams DL, Gillis Tp Fau - Dupree WG, Dupree WG. 1995. Ethanol fixation of sputum sediments for DNA-based detection of Mycobacterium tuberculosis. J Clin Microbiol 33:1558–1561.
    1. Global Laboratory Initiative. 2017. GLI guide to TB specimen referral systems and integrated networks. World Health Organization, Geneva, Switzerland.
    1. DNA Genotek. 2017. OMNIgene.SPUTUM reagent for optimizing samples. DNA Genotek, Ottowa, Canada.
    1. Reeve BWP, McFall SM, Song R, Warren R, Steingart KR, Theron G. 2018. Commercial products to preserve specimens for tuberculosis diagnosis: a systematic review. Int J Tuber Lung Dis 22:741–753. doi:10.5588/ijtld.17.0816.
    1. WHO. 2017. Technical Expert Group meeting report: commercial products for preserving clinical specimens for the diagnosis of tuberculosis. World Health Organization, Geneva, Switzerland.
    1. Cepheid. 2009. Xpert MTB/RIF: two hour detection of MTB and resistance to rifampicin. Cepheid, Sunnyvale, CA.
    1. Rigouts L, Nolasco O, de Rijk P, Nduwamahoro E, Van Deun A, Ramsay A, Arevalo J, Portaels F. 2007. Newly developed primers for comprehensive amplification of the rpoB gene and detection of rifampin resistance in Mycobacterium tuberculosis. J Clin Microbiol 45:252–254. doi:10.1128/JCM.01489-06.
    1. WHO. 2015. Implementing tuberculosis diagnostics: policy framework. World Health Organization, Geneva, Switzerland.
    1. Rieder HLV, Kam KM, Kim SJ, Chonde TM, Trébucq A, Urbanczik R. 2007. Priorities for tuberculosis bacteriology services in low-income countries, 2nd ed International Union Against Tuberculosis and Lung Disease, Paris, France.
    1. Bemer-Melchior P, Drugeon HB. 1999. Inactivation of Mycobacterium tuberculosis for DNA typing analysis. J Clin Microbiol 37:2350–2351.
    1. Sanoussi CN, Affolabi D, Rigouts L, Anagonou S, de Jong B. 2017. Genotypic characterization directly applied to sputum improves the detection of Mycobacterium africanum West African 1, under-represented in positive cultures. PLoS Negl Trop Dis 11:e0005900. doi:10.1371/journal.pntd.0005900.
    1. Promega. 2018. Maxwell 16 DNA purification kits technical manual. . Promega, Madison, WI.
    1. WHO. 2017. Next-generation Xpert MTB/RIF Ultra assay recommended by WHO. World Health Organization, Geneva, Switzerland.
    1. Asandem DA, Asante-Poku A, Asare P, Aboagye SY, Stephen OW, Danso E, Klevor PM, Hayibor KM, Yeboah-Manu D. 2018. OMNIgene SPUTUM: a good transport and decontaminating reagent for tuberculosis testing. Int J Mycobacteriol 7:222–227. doi:10.4103/ijmy.ijmy_102_18.
    1. Maharjan B, Kelly-Cirino CD, Weirich A, Curry PS, Hoffman H, Avsar K, Shrestha B. 2016. Evaluation of OMNIgene.SPUTUM-stabilised sputum for long-term transport and Xpert MTB/RIF testing in Nepal. Int J Tuber Lung Dis 20:1661–1667. doi:10.5588/ijtld.16.0421.
    1. Rabodoarivelo M, Brandao A, Cergole Novella M, C Bombonatte A, Imperiale B, Rakotosamimanana N, Morcillo N, Rasolofo V, Palomino J, Martin A. 2018. Detection of multidrug-resistant tuberculosis from stored DNA samples: a multicenter study. Int J Mycobacteriol 7:40–44. doi:10.4103/ijmy.ijmy_193_17.
    1. Yoo JH. 2018. Review of disinfection and sterilization - back to the basics. Infect Chemother 50:101–109. doi:10.3947/ic.2018.50.2.101.
    1. Tomar R, Dubey VK, Jagannadham MV. 2009. Effect of alkyl alcohols on partially unfolded state of proteinase K: differential stability of alpha-helix and beta-sheet rich regions of the enzyme. Biochimie 91:951–960. doi:10.1016/j.biochi.2009.04.013.
    1. Banada PP, Sivasubramani SK, Blakemore R, Boehme C, Perkins MD, Fennelly K, Alland D. 2010. Containment of bioaerosol infection risk by the Xpert MTB/RIF assay and its applicability to point-of-care settings. J Clin Microbiol 48:3551. doi:10.1128/JCM.01053-10.
    1. Van Deun A, Aung KJ, Hossain A, de Rijk P, Gumusboga M, Rigouts L, de Jong BC. 2015. Disputed rpoB mutations can frequently cause important rifampicin resistance among new tuberculosis patients. Int J Tuber Lung Dis 19:185–190. doi:10.5588/ijtld.14.0651.
    1. Affolabi D, Sanoussi N, Sossou A, Nys T, Bodi O, Esse M, Houeto S, Massou F, de Jong BC, Rigouts L. 2 May 2018. Performance of OMNIgene.SPUTUM (DNA Genotek) and cetylpyridinium chloride for sputum storage prior to mycobacterial culture. J Med Microbiol doi:10.1099/jmm.0.000745.
    1. Zallet J, Olaru ID, Witt AK, Vock P, Kalsdorf B, Andres S, Hillemann D, Kranzer K. 2018. Evaluation of OMNIgene.SPUTUM reagent for mycobacterial culture. Int J Tuber Lung Dis 22:945–949. doi:10.5588/ijtld.17.0020.
    1. Tagliani E, Alagna R, Tafaj S, Hafizi H, Cirillo DM. 2017. Evaluation of Mycobacterium tuberculosis viability in OMNIgene-SPUTUM reagent upon multi-day transport at ambient temperature. BMC Infect Dis 17:663. doi:10.1186/s12879-017-2756-3.
    1. FIND. 2006. MGIT procedure manual. Foundation for Innovative New Diagnostics, Geneva, Switzerland.
    1. Sankar MM, Kumar P, Munawwar A, Singh J, Parashar D, Singh S. 2009. Recovery of Mycobacterium tuberculosis from sputum treated with cetyl pyridinium chloride. J Clin Microbiol 47:4189–4190. doi:10.1128/JCM.01295-09.

Source: PubMed

3
Tilaa